Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-039767

Director acquired 4,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Carol Giltner Director 2019-06-27 Grant or award +4,000 92,818 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Carol Giltner Director 2019-06-27 Grant or award · Non-Qualified Stock Option (Right to Buy) +13,000 13,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…